[1]骆云鹏,LIU Rosa,SALMON Sydney E.阿霉素对重组人肿瘤坏死因子介导的结肠癌细胞(COLO205)细胞毒增敏作用[J].重庆医科大学学报,2001(04):393-396.
LUO Yun - peng, et al. sitization of colon cancer cells (COLO205) treated with Doxorubicin to rHuTNF - mediated cytotoxicity[J]. Journal of Chongqing Medical University, 2001,(4):393-396.
[1]骆云鹏,LIU Rosa,SALMON Sydney E.阿霉素对重组人肿瘤坏死因子介导的结肠癌细胞(COLO205)细胞毒增敏作用[J].重庆医科大学学报,2001(04):393-396. DOI: 10.13406/j.cnki.cyxb.2001.04.011.
LUO Yun - peng, et al. sitization of colon cancer cells (COLO205) treated with Doxorubicin to rHuTNF - mediated cytotoxicity[J]. Journal of Chongqing Medical University, 2001,(4):393-396. DOI: 10.13406/j.cnki.cyxb.2001.04.011.
Objective: To evaluate the sequential action of rHuTNF and doxorubicin (DOX) against hurnan colon cancer cell line (COLO205 ). Method: With clonogenic aSSa(Hamburger -- Salmon methed)
the sequen- tial roles of rHuTNF and DOX on COLO205 were investigated. The dose -- effect relationships of each drug alone and in combination were analyzed by examining the survival fraction of the drug combination. Results: The ac- tion of DOX and rHuTNF against proliferation was found to be schedule -- dependent in colon cancer line CO- LO205;marked synergistic effects were observed in most instances of trearment
when DOX was administered prior to and not following rHuTNF. Chnclusion: The anti -- tumor effect of TNF can be enhanced in the presece of DOX
suggestion that the addition of DOX may interfere with the cellular protective mechanism
causing the tumor cells to become rae susceptible to the cytotoxic action of TNF.
关键词
肿瘤坏死因子阿霉素COLO205克隆生成试验药物序贯作用
Keywords
TNFDoxorubicinCOLO205Clongenic assaySequential ro1es of drugs